CT scans, MRI scans, biopsies and echograms are used to uncover, amongst others, ovarian and uterine cancers. Gynaia, a new spin-off from KU Leuven and UZ Leuven, is working on an AI platform to help analyse ultrasounds faster and more accurately.
Early and more precise cancer diagnosis leads, of course, to better outcomes. Gynaia has raised €2.3 million in seed funding that will be used to develop software and AI technology to enable gynaecologists and sonographers make faster and more accurate diagnoses. The intention is to incorporate the platform into clinical practice through training. It is expected to produce its first tangible results in 2025.
With its branches in Flanders and the United States, Gynaia is targeting international investors. Research and development, however, will primarily take place in Belgium.
A promising breakthrough in women's health.
